Navigation Links
Accuray Receives Prestigious Awards for 2008 Advertising Campaign
Date:1/7/2009

ADDY and Telly Awards Honor CyberKnife Print and TV Ads

SUNNYVALE, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced the company has received three prestigious awards for its 2008 advertising campaign promoting the CyberKnife(R) Robotic Radiosurgery System.

Accuray and RBG Marketing, who created the ads, received recognition from the world-renowned ADDY(R) Awards for their patient-focused print campaign and recognition from the Telly Awards for their television commercial.

Accuray and RBG Marketing received Silver ADDY Awards at both the local chapter and district level for their "Tumors Have Nowhere to Hide" print series, which featured actual patients who were treated with the CyberKnife System. The companies also received a Bronze ADDY Award at the local chapter level for "The Fight of My Life" print campaign, which worked in conjunction with their award-winning television commercial.

The ADDY Awards, presented by the American Advertising Federation, is the world's largest advertising competition. With more than 60,000 entries annually, the ADDY Awards epitomize creative excellence by recognizing all forms of advertising from all types of media, created by all sizes and levels of entrants from anywhere in the world. It is the only creative awards program administered by and for the advertising industry.

"Accuray's receipt of these prestigious awards, in partnership with RBG Marketing, is a testament to the creativity and innovation we bring to all facets of our business," said Eric P. Lindquist, senior vice president and chief marketing officer of Accuray. "Since advertising is one way to spread awareness of the benefits of the CyberKnife System we are pleased that these tools hav
'/>"/>

SOURCE Accuray Incorporated
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery
2. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
3. Accuray to Webcast Senior Management Presentations at Analyst Day Event
4. Accuray Incorporated to Report First Quarter Fiscal Year 2008 Financial Results
5. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO 2007
6. Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting
7. Accuray Reports Record Revenue in First Quarter of Fiscal 2008
8. Accuray Exceeds 4,000 Lung Cancer Patients Treated with CyberKnife(R) System
9. Accuray Incorporated to Report Second Quarter Fiscal Year 2008 Financial Results
10. Accuray Reports Continued Growth in Second Quarter of Fiscal 2008
11. Accurays CyberKnife System Receives 2008 North American Medical Devices Product of the Year Award From Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... In today,s academic medical centers, value ... Now the University HealthSystem Consortium (UHC) has created ... Achieving Cost Efficiencies in Health Care, to ... These new materials, developed with the input of ... practical guide to planning, implementing, and managing all ...
(Date:12/14/2009)... AQUALIPO™ and NaturalFill™ revolutionary new liposuction and fat transfer treatments ... lips all in one minimally invasive treatment. , ... ... of AQUALIPO™ and NaturalFill™ can remove excess fat from the ... help people slim down, reduce facial wrinkling and enhance lips ...
(Date:12/14/2009)... Ill. and HOLLYWOOD, Fla., Dec. 14 /PRNewswire-FirstCall/ ... announced today a definitive agreement to acquire ... a leading provider of laboratory information management ... ,, The acquisition strengthens Abbott,s competitive ... advanced web-based applications to help laboratories efficiently ...
(Date:12/14/2009)... 14 Heska Corporation (Nasdaq: ... leading provider of veterinary diagnostic and specialty ... of the Company,s new DRI-CHEM® 7000 Veterinary ... http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,, Customers receiving these ... clinical chemistry analyzer available to the veterinary ...
(Date:12/14/2009)... Aflac Incorporated announced today that it has priced ... with a coupon of 6.9%. The notes will ... yield 6.984%. The company anticipates using the proceeds ... corporate purposes. ,, Commenting on the pricing of ... Financial Officer Kriss Cloninger III commented: "This debt ...
Breaking Medicine News(10 mins):Health News:University HealthSystem Consortium Offers Value Analysis Professionals Insightful New Resources 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:Heska Announces Installation of New Chemistry Analyzer 2Health News:Heska Announces Installation of New Chemistry Analyzer 3Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 2Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 3Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 4
... of early-stage Parkinson's disease, and may be a good ... disorder,// researchers said., ,A neupro patch developed by ... its effects on 277 people in Canada and the ... to convey a drug called rotigotine that performs ...
... nearly 20% to 50% of patients availing psychiatric services ... a novel think-tank// has come up with a strategy, ... who rely on outreach services may have huge numbers ... ,Schizophrenics could be cajoled into taking their medication ...
... Women who drink alcohol heavily over a short period of ... weeks are likely to face more depression than men, says ... North Dakota School Of Medicine and Health Sciences and other ... women and their history of depression, according to the online ...
... However it is regarded as a psychological disorder. Dr Sabine ... this topic, in Sweden. ,The researchers found out ... bulimia nervosa also suffer from other metabolic disorders. The study ... by a hormonal imbalance. The patients may often be overeating ...
... vital B vitamin is a must in the medicine chest of ... acid could lead to serious birth defects// in the baby. Folic ... heart disease. Now, there appears to be one more feather in ... may actually reduce low frequency hearing loss, researchers said. ,The ...
... final awakening' - Walter Scott// ... president of Iraq, Saddam Hussein, was sent to the gallows for ... that he slaughtered 148 fellow countrymen, who were Shias, and other ... use in all societies to wipe out political dissent. In recent ...
Other Medicine News:Health News:Excessive Male Hormones can Cause Bulimia in Women 2Health News:'Hooded Horror': Death by Hanging 2Health News:'Hooded Horror': Death by Hanging 3
(Date:12/14/2009)... Calif., Dec. 14 The Roberts ... today released the analysis of social responsibility ... world-wide. The report contains a compilation of ... environmental and social reporting of the companies. ... and performance for both environmental and social ...
(Date:12/14/2009)... According to Millennium Research Group (MRG), the global ... of safety devices for small-bore connectors for disposable ... of the enteral feeding device markets in both ... and European Markets for Enteral Feeding Devices 2010 ... will experience the greatest impact from facilities switching ...
(Date:12/14/2009)... Inc. (Nasdaq: MYL ) today announced that ... Index Dec. 21. Mylan,s common shares will also ... Chairman and CEO Robert J. Coury said: "We ... followed index of leading companies. This development marks ... the rapid growth and strong potential of our ...
Breaking Medicine Technology:New Report Grades Sustainability Reporting of Top Pharmaceutical Companies 2New Report Grades Sustainability Reporting of Top Pharmaceutical Companies 3Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 3Mylan Added to NASDAQ-100 Index 2ECI Hires Robin Raff as Director of Strategy 55780 1ECI Hires Robin Raff as Director of Strategy 55780 2Lets Get it Done 21 From Coast to Coast USAction Affiliates Rally This Week for Quality Affordable Health Care 55777 1Lets Get it Done 21 From Coast to Coast USAction Affiliates Rally This Week for Quality Affordable Health Care 55777 2Cost Effective Solution for Patient Testing 3A Introducing Comprehensive and Affordable Molecular Diagnosis With Verifiable Accuracy 55774 1Cost Effective Solution for Patient Testing 3A Introducing Comprehensive and Affordable Molecular Diagnosis With Verifiable Accuracy 55774 2
... Tamoxifen in,a Single Trial , LUTON, UK, ... of a single trial has demonstrated that survival ... switching from,tamoxifen to anastrozole (Arimidex). An analysis of ... The,Journal of Clinical Oncology, confirms that postmenopausal women,who ...
... WIRE)--Jun 18, 2007 - Salix,Pharmaceuticals, Ltd. (NASDAQ:SLXP) ... its Phase III registration trial to,evaluate the ... mg tablet,formulation of balsalazide disodium (balsalazide tablets).,Balsalazide ... 750 mg, an anti-inflammatory drug approved and ...
Other Medicine Technology:Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 2Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 3Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 4Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 5Salix Pharmaceuticals Announces Positive Top Line Results of,Balsalazide Tablets Registration Study 2Salix Pharmaceuticals Announces Positive Top Line Results of,Balsalazide Tablets Registration Study 3
The NexGen CR femoral component is intended for patients who, in the physician's judgement, have good bone stock and whose ligaments provide adequate mediolateral, anteroposterior, and varus/valgus s...
... Genesis II* Total Knee System will define ... more is possible with less - reducing ... fully addressing both clinical and cost situations. ... these design goals, giving surgeons creative solutions ...
Cruciate retaining, posterior stabilized and constrained components....
The Natural-Knee Family is a complete range of interchangeable, anatomically-designed implants with over 14 years of proven clinical results....
Medicine Products: